Testosterone, sex steroids, and aging in neurodegenerative disease after acquired brain injury: a commentary

References

• High WM , Briones-Galang M , Clark JA , Gilkison C , Mossberg KA , Zgaljardic DJ , Masel BE , Urban RJ. Effect of Growth Hormone Replacement Therapy on Cognition after Traumatic Brain Injury. J Neurotrauma. 2010;27(9):1565–75.doi:10.1089/neu.2009.1253.
   PubMed Web of Science ®Google Scholar
• Perry DC , Sturm VE , Peterson MJ , Pieper CF , Bullock T , Boeve BF , Miller BL , Guskiewicz KM , Berger MS , Kramer JH , et al. Traumatic brain injury is associated with subsequent neurologic and psychiatric disease: A meta-analysis. J Neurosurg. 2016;124:511–26.
   PubMed Web of Science ®Google Scholar
• Masel BE , DeWitt DS. Traumatic brain injury: A disease process, not an event. J Neurotrauma. 2010;27:1–12.
   PubMed Web of Science ®Google Scholar
• Daneshvar DH , Riley DO , Nowinski CJ , McKee AC , Stern RA , Cantu RC . Long-term consequences: Effects on normal development profile after concussion. Phys Med Rehabil Clin N Am. 2011;22(ix):683–700.
   PubMedGoogle Scholar
• Adibhatla RM , Hatcher JF . Altered lipid metabolism in brain injury and disorders. Subcell Biochem. 2008;49:241–68.
   PubMedGoogle Scholar
• McKee AC , Cantu RC , Nowinski CJ , Hedley-Whyte ET , Gavett BE , Budson AE , Santini VE , Lee HS , Kubilus CA , Stern RA . Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injuy. J Neuropathol Exp Neurol. 2009;68:709–35.
   PubMed Web of Science ®Google Scholar
• Turkheimer E , Cullum CM , Hubler DW , Paver SW , Yeo RA , Bigler ED . Quantifying cortical atrophy. J Neurol Neurosurg Psychiatry. 1984;47:1314–18.
   PubMed Web of Science ®Google Scholar
• Massman PJ , Bigler ED , Cullum CM , Naugle RI . The relationship between cortical atrophy and ventricular volume. Int J Neurosci. 1986;30:87–99.
   PubMed Web of Science ®Google Scholar
• Schneider HJ , Kreitschmann-Andermahr I , Ghigo E , Stalla GK , Agha A . Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: A systematic review. JAMA. 2007;298:1429–38.
   PubMed Web of Science ®Google Scholar
• Agha A , Rogers B , Sherlock M , O’Kelly P , Tormey W , Phillips J , Thompson CJ . Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab. 2004;89:4929–36.
   PubMed Web of Science ®Google Scholar
• Popovic V , Pekic S , Pavlovic D , Maric N , Jasovic-Gasic M , Djurovic B , Medic Stojanoska M , Zivkovic V , Stojanovic M , Doknic M , et al. Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress. J Endocrinol Invest. 2004;27:1048–54.
   PubMed Web of Science ®Google Scholar
• Schneider HJ , Schneider M , Saller B , Petersenn S , Uhr M , Husemann B , von Rosen F , Stalla GK . Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol. 2006;154:259–65.
   PubMed Web of Science ®Google Scholar
• Kopczak A , Kilimann I , von Rosen F , Krewer C , Schneider HJ , Stalla GK , Schneider M . Screening for hypopituitarism in 509 patients with traumatic brain injury or subarachnoid hemorrhage. J Neurotrauma. 2014;31:99–107.
   PubMed Web of Science ®Google Scholar
• Barton DJ , Kumar RG , McCullough EH , Galang G , Arenth PM , Berga SL , Wagner AK . Persistent hypogonadotropic hypogonadism in men after severe traumatic brain injury: Temporal hormone profiles and outcome prediction. J Head Trauma Rehabil. 2016;31:277–87.
   PubMed Web of Science ®Google Scholar
• Dohle GR , Smit M , Weber RF . Androgens and male fertility. World J Urol. 2003;21:341–45.
   PubMed Web of Science ®Google Scholar
• Mellon SH , Griffin LD , Compagnone NA . Biosynthesis and action of neurosteroids. Brain Res Brain Res Rev. 2001;37:3–12.
   PubMed Web of Science ®Google Scholar
• Iqbal MJ , Dalton M , Sawers RS . Binding of testosterone and oestradiol to sex hormone binding globulin, human serum albumin and other plasma proteins: Evidence for non-specific binding of oestradiol to sex homrone binding globulin. Clin Sci. 1983;64:307–14.
   PubMed Web of Science ®Google Scholar
• Papasozomenos S , Shanavas A . Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: Implications for Alzheimer’s disease. Proc Natl Acad Sci U S A. 2002;99:1140–45.
   PubMed Web of Science ®Google Scholar
• Veiga S , Garcia-Segura LM , Azcoitia I . Neuroprotection by the steroids pregnenolone and dehydroepiandrosterone is mediated by the enzyme aromatase. J Neurobiol. 2003;56:398–406.
   PubMedGoogle Scholar
• Hammond J , Le Q , Goodyer C , Gelfand M , Trifiro M , LeBlanc A . Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J Neurochem. 2001;77:1319–26.
   PubMed Web of Science ®Google Scholar
• Reddy DS . Neurosteroids: Endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113–37.
   PubMed Web of Science ®Google Scholar
• Tirassa P , Thiblin I , Ågren G , Vigneti E , Aloe L , Stenfors C . High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain. J Neurosci Res. 1997;47:198–207.
   PubMed Web of Science ®Google Scholar
• Kujawa KA , Tanzer L , Jones KJ . Inhibition of the accelerative effects of testosterone on hamster facial nerve regeneration by the antiandrogen flutamide. Exp Neurol. 1995;133:138–43.
   PubMed Web of Science ®Google Scholar
• Jones KJ , Sotrer PD , Drengler SM , Oblinger MM . Differential regulation of cytoskeletal gene expression in hamster facial motoneurons: Effects of axotomy and testosterone treatment. J Neurosci Res. 1999;57:817–23.
   PubMed Web of Science ®Google Scholar
• Feldman HA , Longcope C , Derby CA , Johannes CB , Araujo AB , Coviello AD , Bremner WJ , McKinlay JB . Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589–98.
   PubMed Web of Science ®Google Scholar
• Gray A , Feldman HA , McKinlay JB , Longcope C . Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991;73:1016–25.
   PubMed Web of Science ®Google Scholar
• Harman SM , Metter EJ , Tobin JD , Pearson J , Blackman MR . Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724–31.
   PubMed Web of Science ®Google Scholar
• Vermeulen A , Kaufman JM , Giagulli VA . Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab. 1996;81:1821–26.
   PubMed Web of Science ®Google Scholar
• Muller M , den Tonkelaar I , Thijssen JH , Grobbee DE , van der Schouw YT . Endogenous sex hormones in men aged 40–80 years. Eur J Endocrinol. 2003;149:583–89.
   PubMed Web of Science ®Google Scholar
• Mammi C , Calanchini M , Antelmi A , Cinti F , Rosano GM , Lenzi A , Caprio M , Fabbri A . Androgens and adipose tissue in males: Acomplex and reciprocal interplay. Int J Endocrinol. 2012;2012:789653.
   PubMedGoogle Scholar
• Atwood CS , Bowen RL . The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease. Horm Behav. 2015;76:63–80.
   PubMed Web of Science ®Google Scholar
• Atwood CS , Meethal SV , Liu T , Wilson AC , Gallego M , Smith MA , Bowen RL . Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence. J Neuropathol Exp Neurol. 2005;64:93–103.
   PubMed Web of Science ®Google Scholar
• Bowen RL , Verdile G , Liu T , Parlow AF , Perry G , Smith MA , Martins RN , Atwood CS . Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem. 2004;279:20539–45.
   PubMed Web of Science ®Google Scholar
• Bowen RL , Smith MA , Harris PL , Kubat Z , Martins RN , Castellani RJ , Perry G , Atwood CS . Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer’s disease pathology. J Neurosci Res. 2002;70:514–18.
   PubMed Web of Science ®Google Scholar
• Bowen RL , Isley JP , Atkinson RL . An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol. 2000;12:351–54.
   PubMed Web of Science ®Google Scholar
• Militello A , Vitello G , Lunetta C , Toscano A , Maiorana G , Piccoli T , La Bella V . The serum level of free testosterone is reduced in amyotrophic lateral sclerosis. J Neurol Sci. 2002;195:67–70.
   PubMed Web of Science ®Google Scholar
• Pike CJ , Carroll JC , Rosario ER , Barron AM . Protective actions of sex steroid hormones in Alzheimer’s disease. Front Neuroendocrinol. 2009;30:239–58.
   PubMed Web of Science ®Google Scholar
• Fukai S , Akishita M , Yamada S , Toba K , Ouchi Y . Effects of testosterone in older men with mild-to-moderate cognitive impairment. J Am Geriatr Soc. 2010;58:1419–21.
   PubMed Web of Science ®Google Scholar
• Okun MS , Crucian GP , Fischer L , Walter BL , Testa CM , Vitek JL , DeLong MR , Hanfelt J , Huang X . Testosterone deficiency in a Parkinson’s disease clinic: Results of a survey. J Neurol Neurosurg Psychiatry. 2004;75:165–66.
   PubMedGoogle Scholar
• Gouras GK , Xu H , Gross RS , Greenfield JP , Hai B , Wang R , Greengard P . Testosterone reduces neuronal secretion of Alzheimer’s beta-amyloid peptides. Proc Natl Acad Sci U S A. 2000;97:1202–05.
   PubMed Web of Science ®Google Scholar
• Almeida OP , Waterreus A , Spry N , Corica T , Martins G , Martins RN , Flicker L . Effect of testosterone deprivation on the cognitive performance of a patient with Alzheimer’s disease. Int J Geriatr Psychiatry. 1996;2001:823–25.
   Google Scholar
• Griesbach GS , Masel BE , Helvie RE , Ashley MJ . The impact of traumatic brain injury on later life: effects on normal aging and neurodegenerative diseases. J Neurotrauma. 2018;35:17–24.
   PubMed Web of Science ®Google Scholar
• Janowsky JS , Chavez B , Orwoll E . Sex steroids modify working memory. J Cogn Neurosci. 2000;12:407–14.
   PubMed Web of Science ®Google Scholar
• Cherrier MM , Asthana SM , Plymate SM , Baker L , Matsumoto AM , Peskind E , Raskind MA , Brodkin K , Bremner W , Petrova A , et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001;57:80–88.
   PubMed Web of Science ®Google Scholar
• Seidman SN , Rabkin JG . Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord. 1998;48:157–61.
   PubMed Web of Science ®Google Scholar
• Sternbach H . Age-associated testosterone decline in men: Clinical issues for psychiatry. Am J Psychiatry. 1998;155:1310–18.
   PubMed Web of Science ®Google Scholar
• Zitzmann M . Testosterone and the brain. Aging Male. 2006;9:195–99.
   PubMed Web of Science ®Google Scholar
• Lim D , Flicker L , Dharamarajan A , Martins RN . Can testosterone replacement decrease the memory problem of old age? Med Hypotheses. 2003;60:893–96.
   PubMed Web of Science ®Google Scholar
• Yoshizawa A , Clemmons DR . Testosterone and insulin-like growth factor (IGF) I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts. J Clin Endocrinol Metab. 2000;85:1627–33.
   PubMed Web of Science ®Google Scholar
• Gouras GK , Xu H , Gross RS , Greenfield JP , Hai B , Wang R , Greengard P . Testosterone reduces neuronal secretion of Alzheimer’s beta-amyloid peptides. Proc Natl Acad Sci U S A. 2000;97:1202–05.
   PubMed Web of Science ®Google Scholar
• Corona G , Rastrelli G , Guaraldi F , Tortorici G , Reismann Y , Sforza A , Maggi M . An update on heart disease risk associated with testosterone boosting medications. Expert Opin Drug Saf. 2019.
   PubMed Web of Science ®Google Scholar
• Corona G , Rastrelli G , Reisman Y , Sforza A , Maggi M . The safety of available treatments of male hypogonadism in organic and functional hypogonadism. Expert Opin Drug Saf. 2018;17:277–92.
   PubMed Web of Science ®Google Scholar
• Miner M , Morgentaler A , Khera M , Traish AM . The state of testosterone therapy since the FDA’s 2015 labelling changes: Indications and cardiovascular risk. Clin Endocrinol (Oxf). 2018;89:3–10.
   PubMed Web of Science ®Google Scholar
• Gagliano-Juca T , Basaria S . Testosterone replacement therapy and cardiovascular risk. Nat Rev Cardiol. 2019;16:555–74.
   PubMed Web of Science ®Google Scholar
• A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men (TRAVERSE). 2018 [Accessed 2020 Mar 9 . https://clinicaltrials.gov/ct2/show/NCT03518034
   Google Scholar